Products

First vaccine against COVID-19 in Latin America.

Monoclonal antibodies Nr. Reference code Name Specificity Subclass 1 3.005 CBSSBm.1 Bm-86 (intestinal protein...

Polyclonal antibodies Nr. Reference Code Name Specificity Source 1 4.002 CBSS anti p64K in...

Antibodies conjugated to peroxidase Nr. Reference Code Name Species 1 5.001 CBSSBm.2-HRP Murine 2...

Recombinant proteins Nr.  Reference Code Name Description 1 6.001.00 NS3 c33c recombinant protein Use...

HeberZima Taq ADN Polimerase Reference code: 2.001.00 Source: E. coli strain carrying the gene...

HeberZima Pwo ADN Polimerase Reference code: 2.002.00 Source: E. coli strain carrying the cloned...

Hemerubin Nr.: 1 Reference code: 7.000 Name: Ram blood Origin: Ram Presentation: Bag with...

Rapid, one-step test for the detection of protective levels of antibodies against Boophilus microplus...

Anti-COVID-19 vaccine candidate, nasal application.

Interferon alfa 2b for nasal application for the prophylaxis of SARS-CoV-2 virus infection.

Jusvinza controls hyperinflammation, regulates the immune response and reduces the risk of mortality

First-in-class: only therapy for the effective healing of DFU and complex wounds

Combination of interferon alpha 2b and gamma for basal cell carcinoma.

Antiviral, antiproliferative and immunomodulatory.